GCM Grosvenor [GCMG] vs BlackRock Science [BSTZ] Detailed Stock Comparison
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: GCM Grosvenor Inc. wins in 5 metrics, BlackRock Science and Technology Trust II wins in 7 metrics, with 2 ties. BlackRock Science and Technology Trust II appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | GCM Grosvenor Inc. | BlackRock Science and Technology Trust II | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 25.83 | 5.48 | BlackRock Science and Technology Trust II |
| Price-to-Book Ratio | 24.38 | N/A | N/A |
| Debt-to-Equity Ratio | 385.24 | 0.00 | Tie |
| PEG Ratio | 10.27 | N/A | N/A |
| EV/EBITDA | 7.32 | N/A | N/A |
| Profit Margin (TTM) | 8.18% | 0.00% | GCM Grosvenor Inc. |
| Operating Margin (TTM) | 31.01% | 0.00% | GCM Grosvenor Inc. |
| EBITDA Margin (TTM) | 31.01% | N/A | N/A |
| Return on Equity | 765.86% | 18.31% | GCM Grosvenor Inc. |
| Return on Assets (TTM) | 11.69% | 17.93% | BlackRock Science and Technology Trust II |
| Free Cash Flow (TTM) | $175.04M | $877.82M | BlackRock Science and Technology Trust II |
| Dividend Yield | 4.87% | 12.35% | BlackRock Science and Technology Trust II |
| 1-Year Return | -15.70% | 56.86% | BlackRock Science and Technology Trust II |
| Price-to-Sales Ratio (TTM) | 1.19 | 5.61 | GCM Grosvenor Inc. |
| Enterprise Value | $1.01B | $0 | GCM Grosvenor Inc. |
| EV/Revenue Ratio | 1.82 | 0.00 | Tie |
| Revenue per Share (TTM) | $11 | N/A | N/A |
| Earnings per Share (Diluted) | $0.42 | $4.65 | BlackRock Science and Technology Trust II |
| Beta (Stock Volatility) | 0.88 | N/A | N/A |
| Short % of Float | 4.17% | 0.08% | BlackRock Science and Technology Trust II |
GCM Grosvenor Inc. vs BlackRock Science and Technology Trust II Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| GCM Grosvenor Inc. | -5.04% | -7.51% | -9.76% | -13.22% | -9.36% | -11.68% |
| BlackRock Science and Technology Trust II | -2.03% | 4.25% | 14.65% | 39.53% | 38.72% | 34.03% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| GCM Grosvenor Inc. | -15.70% | 50.78% | -5.43% | 9.03% | 9.03% | 9.03% |
| BlackRock Science and Technology Trust II | 56.86% | 70.02% | -19.41% | 46.15% | 46.15% | 46.15% |
Performance & Financial Health Analysis: GCM Grosvenor Inc. vs BlackRock Science and Technology Trust II
| Metric | GCMG | BSTZ |
|---|---|---|
| Market Information | ||
| Market Cap | $657.37M | $1.77B |
| Market Cap Category | Small cap | Small cap |
| 10 Day Avg. Volume | 398,152 | 188,948 |
| 90 Day Avg. Volume | 643,744 | 211,439 |
| Last Close | $9.98 | $30.92 |
| 52 Week Range | $9.30 - $13.22 | $19.23 - $31.58 |
| % from 52W High | -24.51% | -2.09% |
| All-Time High | $15.36 (Dec 07, 2020) | $43.76 (Nov 08, 2021) |
| % from All-Time High | -35.03% | -29.34% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.07% | N/A |
| Quarterly Earnings Growth | 1.49% | N/A |
| Financial Health | ||
| Profit Margin (TTM) | 0.08% | 0.00% |
| Operating Margin (TTM) | 0.31% | 0.00% |
| Return on Equity (TTM) | 7.66% | 0.18% |
| Debt to Equity (MRQ) | 385.24 | 0.00 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $0.45 | N/A |
| Cash per Share (MRQ) | $3.98 | N/A |
| Operating Cash Flow (TTM) | $183.54M | $7.07M |
| Levered Free Cash Flow (TTM) | $94.21M | $314.36M |
| Dividends | ||
| Last 12-Month Dividend Yield | 4.87% | 12.35% |
| Last 12-Month Dividend | $0.57 | $2.64 |
Valuation & Enterprise Metrics Analysis: GCM Grosvenor Inc. vs BlackRock Science and Technology Trust II
| Metric | GCMG (Apr 24, 2026) | BSTZ (Apr 24, 2026) |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 25.83 | 5.48 |
| Forward P/E | 10.27 | N/A |
| PEG Ratio | 10.27 | N/A |
| Price to Sales (TTM) | 1.19 | 5.61 |
| Price to Book (MRQ) | 24.38 | N/A |
| Market Capitalization | ||
| Market Capitalization | $657.37M | $1.77B |
| Enterprise Value | $1.01B | $0 |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 1.82 | 0.00 |
| Enterprise to EBITDA | 7.32 | N/A |
| Risk & Other Metrics | ||
| Beta | 0.88 | N/A |
| Book Value per Share (MRQ) | $0.45 | N/A |
Financial Statements Comparison: GCM Grosvenor Inc. vs BlackRock Science and Technology Trust II
Financial Metrics
Loading Financial Charts...
Revenue
Operating Margin
Profit Margin
Long Term Debt
Income Flow Analysis
Financial Statements Comparison
Income Statement
| Metric | GCMG (2025) | BSTZ (2025) |
|---|---|---|
| Revenue/Sales | 565.55M | 316.13M |
| Cost of Goods Sold | N/A | N/A |
| COGS % of Revenue | 0.0% | 0.0% |
| Gross Profit | N/A | N/A |
| Gross Margin | 0.0% | 0.0% |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | 149.71M | N/A |
| Operating Margin | 26.5% | 0.0% |
| EBITDA | 160.42M | N/A |
| EBITDA Margin | 28.4% | 0.0% |
| Pre-Tax Income | 154.94M | 314.36M |
| Pre-Tax Income % of Revenue | 27.4% | 99.4% |
| Income Tax | 12.90M | N/A |
| Income Tax % of Revenue | 2.3% | 0.0% |
| Net Income (Profit) | 142.04M | 314.36M |
| Profit Margin | 25.1% | 99.4% |
Balance Sheet & Liquidity Metrics
| Metric | GCMG (2025) | BSTZ (2025) |
|---|---|---|
| Cash & Equivalents | 242.12M | 722,140 |
| Total Current Assets | 354.52M | N/A |
| Total Current Assets % of Revenue | 62.7% | 0.0% |
| Total Current Liabilities | 64.74M | N/A |
| Total Current Liabilities % of Revenue | 11.4% | 0.0% |
| Long-Term Debt | 480.23M | N/A |
| Long-Term Debt % of Revenue | 84.9% | 0.0% |
| Total Shareholders Equity | 127.43M | 1.72B |
| Retained Earnings | -16.26M | 774.43M |
| Retained Earnings % of Revenue | -2.9% | 245.0% |
| Property, Plant & Equipment | 40.02M | N/A |
Cash Flow Statement Comparison
| Metric | GCMG (2025) | BSTZ (2025) |
|---|---|---|
| Operating Cash Flow | 232.04M | 7.07M |
| Operating Cash Flow % of Revenue | 41.0% | 2.2% |
| Capital Expenditures | -8.50M | N/A |
| Free Cash Flow | 175.04M | 877.82M |
| FCF Margin | 31.0% | 277.7% |
| Debt Repayment | -4.38M | N/A |
| Common Stock Repurchase | -30.66M | -723.97M |
Short Interest & Institutional Ownership Analysis
| Metric | GCMG | BSTZ |
|---|---|---|
| Shares Short | 1.89M | 57,419 |
| Short Ratio | 2.31 | 0.39 |
| Short % of Float | 4.17% | 0.08% |
| Shares Outstanding | 60.72M | 68.74M |
| Float Shares | 59.20M | N/A |
| % Held by Insiders | 2.69% | 0.01% |
| % Held by Institutions | 103.36% | 30.88% |
| % Held by Public | -6.05% | 69.11% |
Dividend Analysis & Yield Comparison: GCM Grosvenor Inc. vs BlackRock Science and Technology Trust II
| Metric | GCMG | BSTZ |
|---|---|---|
| Last 12-Month Dividend | $0.57 | $2.64 |
| Last 12-Month Dividend Yield | 4.87% | 12.35% |
| 3-Year Avg Annual Dividend | $0.48 | $2.19 |
| 3-Year Avg Dividend Yield | 1.13% | 0.94% |
| 3-Year Total Dividends | $1.45 | $6.56 |
| Ex-Dividend Date | Mar 02, 2026 | Mar 13, 2026 |